Spero Therapeutics News, Spero Therapeutics Quote, SPRO Quote

Spero Therapeutics (NQ:SPRO) Delayed: 2.28 +0.17 (8.06%)

Prev. Close

$2.11

Today 6M 1Y 5Y

Open

$2.51

52 Wk High

$3.85

52 Wk Low

$1.25

Day High

$2.51

Day Low

$2.15

P/E

N/A

EPS

$-0.28

Volume

7,195,321

Friends, Peers and Foes (?): GSK CMPS (more...)

ALERTS | RSS

Jun 17, 2026 04:21 PM FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi
Jun 17, 2026 04:21 PM Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
Jun 17, 2026 12:36 PM Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
Jun 17, 2026 11:09 AM GSK receives FDA approval for oral antibiotic to treat UTIs
May 28, 2026 06:30 AM Compass Pathways elects Kathleen Tregoning to board of directors
May 28, 2026 06:30 AM Compass Pathways Elects Kathleen Tregoning to Board of Directors
May 13, 2026 04:09 PM SmartPros Ltd. (SPRO) Reports Q1 Loss of $0.13
May 13, 2026 04:06 PM Form 10-Q Spero Therapeutics, Inc. For: Mar 31
May 13, 2026 04:05 PM Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
May 13, 2026 04:02 PM Form 8-K Spero Therapeutics, Inc. For: May 13

Entities mentioned with SPRO

View All Entities